Literature DB >> 10534580

DNA vaccines: basic mechanism and immune responses (Review).

H L Robinson1.   

Abstract

DNA vaccines raise immune responses by expressing proteins in vaccinated hosts. Responses are raised by nanogram levels of protein expression. Popular methods of DNA delivery include intramuscular (i. m.) injections of DNA in saline and gene gun delivery of DNA-coated gold beads to the epidermis. Professional antigen-presenting cells derived from the bone marrow present DNA-expressed antigens to T-cells. Following gene gun immunizations directly transfected dendritic cells present antigens, whereas following i.m. immunizations both directly transfected dendritic cells and macrophages can present antigen. For both methods of DNA delivery, non-lymphoid cells can serve as factories of antigen for professional antigen presenting cells. Gene gun immunizations depend on antigen expression at the skin target whereas i.m. immunizations are largely independent of DNA expression in the muscle target. For both methods, antigen expression capable of initiating an immune response persists for about one month. intramuscular deliveries of DNA tend to raise type 1 T-cell help for intracellular and plasma membrane antigens but type 2 T-cell help for secreted antigens. Gene gun immunizations tend to raise type 2 T-cell help for both cell-associated and secreted antigens. In mice, DNA-raised immune responses can be equivalent to those raised by viral infections for both the height and longevity of antibody and cytotoxic T-cell responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534580     DOI: 10.3892/ijmm.4.5.549

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  18 in total

Review 1.  Tracking dendritic cells in vivo: insights into DC biology and function.

Authors:  Huiming Hon; Joshy Jacob
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Birth control vaccine targeting leukemia inhibitory factor.

Authors:  Angela R Lemons; Rajesh K Naz
Journal:  Mol Reprod Dev       Date:  2011-12-02       Impact factor: 2.609

3.  Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis.

Authors:  M M Liu; Z G Yuan; G H Peng; D H Zhou; X H He; C Yan; C C Yin; Y He; R Q Lin; H Q Song; X Q Zhu
Journal:  Parasitol Res       Date:  2010-02-23       Impact factor: 2.289

Review 4.  Specific immunotherapy of cancer in elderly patients.

Authors:  S Matzku; M Zöller
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  Construction of a Novel DNA Vaccine Candidate encoding LmSTI1-PpSP42 Fusion Protein from Leishmania major and Phlebotomus papatasi against Cutaneous Leishmaniasis.

Authors:  Touraj Miandoabi; Fariborz Bahrami; Vahideh Moein Vaziri; Soheila Ajdary
Journal:  Rep Biochem Mol Biol       Date:  2018-10

6.  Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate.

Authors:  Ranajit Pal; Shixia Wang; V S Kalyanaraman; B C Nair; Stephen Whitney; Timothy Keen; Lindsey Hocker; Lauren Hudacik; Nicolas Rose; Anthony Cristillo; Innocent Mboudjeka; Siyuan Shen; Te-Hui Wu-Chou; David Montefiori; John Mascola; Shan Lu; Phillip Markham
Journal:  J Med Primatol       Date:  2005-10       Impact factor: 0.667

7.  Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies.

Authors:  Kelly R Young; Benjamin E Teal; Yvonne Brooks; Thomas D Green; Joseph F Bower; Ted M Ross
Journal:  AIDS Res Hum Retroviruses       Date:  2004-11       Impact factor: 2.205

8.  Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells.

Authors:  Venkataswarup Tiriveedhi; Timothy P Fleming; Peter S Goedegebuure; Michael Naughton; Cynthia Ma; Craig Lockhart; Feng Gao; William E Gillanders; T Mohanakumar
Journal:  Breast Cancer Res Treat       Date:  2012-06-08       Impact factor: 4.872

9.  Evaluation of humoral and cellular immune responses to a DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats.

Authors:  Zhao Xiao; Long Juan; Yun Song; Zhang Zhijian; Jin Jing; Yu Kun; Hao Yuna; Dai Dongfa; Ding Lili; Tan Liuxin; Liang Fei; Liu Nan; Yuan Fang; Sun Yuying; Xi Yongzhi
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

10.  Protective immune response in BALB/c mice induced by DNA vaccine of the ROP8 gene of Toxoplasma gondii.

Authors:  Sonaimuthu Parthasarathy; Mun Yik Fong; Kalyanasundaram Ramaswamy; Yee Ling Lau
Journal:  Am J Trop Med Hyg       Date:  2013-03-18       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.